SpassageQ gets FDA nod

South Korean medical AI company SpassMed has received the United States Food and Drug Administration’s 510(k) clearance for its AI-powered sepsis detection software.

The AI solution called SpassageQ has been approved as software as a medical device for identifying sepsis, anaphylaxis, and hypovolemic shock. MobiHealthNews